Bid Price | 1330.00p | High Price | 1352.00p |
---|
Ask Price | 1450.00p | Low Price | 1352.00p |
---|
Open Price | 1390.00p | Spread | 8.28% |
---|
Prev Close | 1390.00p | Volume | 2 |
---|
4Basebio PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Oct 3, 2024 | 1390.00 | 1352.00 | 1352.00 | 1390.00 | 3 |
Oct 2, 2024 | 1390.00 | 1363.00 | 1352.00 | 1390.00 | 25 |
Oct 1, 2024 | 1390.00 | 1450.00 | 1352.00 | 1390.00 | 934 |
Sep 30, 2024 | 1390.00 | 1400.00 | 1400.00 | 1390.00 | 1,000 |
Sep 27, 2024 | 1390.00 | 1404.40 | 1404.40 | 1390.00 | 149 |
More 4Basebio PLC Historic Prices >4Basebio PLC Information
Name | 4Basebio PLC | Index | FTSE AIM All Share |
---|
ISIN | GB00BMCLYF79 | Epic | 4BB |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 500 | Trading Status | Closed |
---|
Shares in Issue | 12.81 m | Prev Close | 1390.00p |
---|
PE Ratio | | Market Cap | £178.07 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | -£0.45 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 2.72687 | Quick Ratio | 1.534626 |
---|
4Basebio PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
21/09/24 | SELL | Joseph Fernandez | NED | 95,916 @ £15.00 | £1,438,740.00 |
21/09/24 | SELL | Heikki Lanckriet | CEO | 315,706 @ £15.00 | £4,735,590.00 |
21/09/24 | SELL | David Roth | FD | 101,834 @ £15.00 | £1,527,510.00 |
21/09/24 | SELL | Amy Walker | ED | 11,459 @ £15.00 | £171,885.00 |
05/02/24 | SELL | Heikki Lanckriet | CEO | 45,322 @ £6.60 | £299,125.00 |
05/02/24 | SELL | David Roth | FD | 38,292 @ £6.60 | £252,727.00 |
02/02/24 | EXR | Heikki Lanckriet | CEO | 211,863 @ £1.18 | £249,998.00 |
02/02/24 | EXR | David Roth | FD | 179,000 @ £1.18 | £211,220.00 |
13/07/22 | TIN | Heikki Lanckriet | CEO | 29,000 @ £0.00 | £0.00 |
13/07/22 | TOUT | Heikki Lanckriet | CEO | 29,000 @ £0.00 | £0.00 |
More 4Basebio PLC Director Deals >4Basebio PLC News